Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group

The treatment of neovascular (wet) age-related macular degeneration (AMD) with ranibizumab is now very well established in terms of efficacy and safety. Recent clinical trials and real-world studies have demonstrated the advantages of a Treat-and-Extend (T&E) regimen, and many hospital departmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoaku, Winfried, Balaskas, Konstantinos, Cudrnak, Tomas, Downey, Louise, Groppe, Markus, Mahmood, Sajjad, Mehta, Hemal, Mohamed, Quresh, Mushtaq, Bushra, Severn, Philip, Vardarinos, Athanasios, Yang, Yit, Younis, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136415/
https://www.ncbi.nlm.nih.gov/pubmed/30237693
http://dx.doi.org/10.2147/OPTH.S174560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136415/
https://www.ncbi.nlm.nih.gov/pubmed/30237693
http://dx.doi.org/10.2147/OPTH.S174560

Ejemplares similares